HealthInvestor Asia Summit 2018
Financial intelligence for Asia's healthcare markets
Remember me:

Analysis: iKang to go private at US$41.20 per share

CFO Luke Chen’s reticence on the Q3 earnings call on Friday now makes sense. Jack Ma’s Yunfeng Capital and Alibaba Investment will buy out iKang Healthcare Group, China’s largest private preventive healthcare services provider, for around US$1.4 billion.

They will pay US$41.20 per Class A common share or US$20.60 per American depositary share. This is a 15% premium over the closing price on 9 March, and a 24.7% premium over iKang’s 30-day VWAP.

It is noticeable too that the price is a distinct improvement on the US$40.00 per share offer made in mid March, though at the lower end of the US$40.00-US$50.00 offer made in June 2016.

After the takeover, iKang will delist fom Nasdaq and survive as a subsidiary of an SPV created by Yunfeng Capital and Alibaba called IK Healthcare

On the unanimous recommendation of the special committee formed by the independent directors of the board of directors, iKang’s board has recommended that shareholders vote to authorise and approve the move.

The two-thirds majority required by shareholders for the takeover to proceed is expected to pass easily and the deal is expected to close in Q3 this year.

Yunfeng Capital and Alibaba intend to fund the takeover through a combination of US$1.15 billion equity debt and rollover financing.

JP Morgan Securities is financial advisor to the special committee; Simpson Thacher & Bartlett is US legal counsel to the special committee; Walkers is Cayman Islands legal counsel to the special committee; and Junhe is China legal counsel to the special committee. Davis Polk & Wardwell is serving as US legal counsel to the company, and King & Wood Mallesons is China legal counsel to the company.

Last week iKang reported a 93% rise in Q3 profits to US$27.1 million on revenues that were up 33.5% to US$206.4 million. For the year to date, profits are up 127.7% to US$50.1 million with revenues up 26.3% to US$474.4 million.

As soon as the news broke, iKang shares jumped 7.3% to US$19.87. They closed the day at US$19.95.

Posted on: 28/03/2018 UTC+08:00


Shares in orthopaedic specialists Asian Healthcare Specialists (AHS) shot up 52% at the open on their Catalist debut today.
Private equity firm Permira’s A$690 million (US$536 million) five-year leveraged buyout loan to help it acquire EQT’s stake in I-MED Radiology Network, Australia’s largest radiology company, has been flexed down.
Joanne Hannah has resigned as chief executive of Total Face Group, the first medical aesthetics company to list on the ASX, effective 1 May.
Lianluo Smart, which develops medical devices and wearable sleep respiratory products, has signed a strategic cooperation agreement with Meinian Onehealth Healthcare, the second largest healthcare provider in China.
After a choppy day of trading that saw shares in HKE Holdings, a Singapore-based contractor specialising in the medical and healthcare sectors, rise as much as 10%, they closed up 1.82% on their debut yesterday.
Summerset Group, New Zealand’s third-largest listed retirement village operator, has purchased land to build a retirement village in the suburb of Te Awa. The 9-ha property will be Summerset’s fourth in Hawke’s Bay. It already has villages in Havelock North, Hastings and Taradale.
Metlifecare, New Zealand’s second-largest listed retirement village operator, has said that its purchase of a 5.3 hectare waterfront site at Orion Point in Hobsonville, West Auckland, is now unconditional. The deal was announced at the end of October last year.
Hong Kong care home operator Pine Care Group has signed a management agreement with Zhejiang Yada Real Estate to operate and manage the Wuzhen Graceland Day Care Centre in Wuzhen, Zhejiang. Financial terms have not been disclosed.


In Vietnam, population and GDP growth have encouraged the country to think beyond technology in providing more health for more people.
Focused initiatives drive down medical inflation by more than 50 percentage points, according to a new report from Aon Asia Healthcare.
The Japanese healthcare system is a shining example of strength and resilience. At an average lifespan of 84 years, the Japanese society is not only the healthiest but also the "oldest" in the world. However, the challenges presented by an ageing population pose serious threats to the sustainability of the Japanese health system.
Susann Roth, senior social development specialist, Asian Development Bank, explains how investing in energy makes people healthier.
CFO Luke Chen’s reticence on the Q3 earnings call on Friday now makes sense. Jack Ma’s Yunfeng Capital and Alibaba Investment will buy out iKang Healthcare Group, China’s largest private preventive healthcare services provider, for around US$1.4 billion.
Following news that Malaysian sovereign wealth fund Khazanah Nasional will acquire Prince Court Medical Centre (PCMC) from Petronas, IHH Healthcare, Asia’s largest healthcare company, has signed an agreement with Khazanah to look after the day-to-day running of the medical centre.
Malaysian-based primary healthcare provider Qualitas Medical Group is due to push the button on its S$150 million (US$114 million) IPO in Singapore next week. It will be the first mainboard healthcare listing since IHH Healthcare floated in Kuala Lumpur and Singapore in July 2012.
Sumit Sharma, head of health & life sciences, Asia Pacific, at Oliver Wyman, and Matt Zafra, engagement manager, health & life sciences, Oliver Wyman, look at the four themes that are going to dominate healthcare this year.
my images


Hedge Fund Focus

HealthInvestor Asia twitter feed
HIA Indices